AI Optics, Inc.
AI Optics is dedicated to transforming point-of-care diagnostics through innovative AI-powered retinal screening technology. The company aims to increase access to eye screening and empower healthcare professionals to make informed decisions quickly, ultimately improving patient outcomes and revolutionizing medical diagnostics. By developing portable hardware and AI-based software, AI Optics brings eye screening out of specialist offices and into primary care and retail health settings, making early diagnosis reliable, efficient, and user-friendly.
Industries
Nr. of Employees
small (1-50)
Patents
Identification of diseases with portable medical diagnostics instruments that utilize artificial intelligence
US-12193746-B1
View DetailsInterchangeable imaging modules for a medical diagnostics device with integrated artificial intelligence capabilities
US-12178392-B2
View DetailsPortable medical diagnostics device with integrated artificial intelligence capabilities
US-11950847-B1
View Details
Identification of diseases with portable medical diagnostics instruments that utilize artificial intelligence
US-12193746-B1
View DetailsInterchangeable imaging modules for a medical diagnostics device with integrated artificial intelligence capabilities
US-12178392-B2
View DetailsPortable medical diagnostics device with integrated artificial intelligence capabilities
US-11950847-B1
View DetailsProducts
Handheld FDA-cleared retinal imaging device (portable fundus camera)
A portable, rechargeable handheld fundus camera designed to capture high-quality color and infrared retinal images with onboard image processing; cleared through the FDA 510(k) pathway for retinal imaging.
Portable on-device AI retinal screening system (investigational)
A handheld retinal imaging platform that integrates on-device AI screening modules for automated detection of retinal diseases (diabetic retinopathy, AMD, glaucoma), designed for point-of-care use and offline operation with later synchronization to clinical systems.
Handheld FDA-cleared retinal imaging device (portable fundus camera)
A portable, rechargeable handheld fundus camera designed to capture high-quality color and infrared retinal images with onboard image processing; cleared through the FDA 510(k) pathway for retinal imaging.
Portable on-device AI retinal screening system (investigational)
A handheld retinal imaging platform that integrates on-device AI screening modules for automated detection of retinal diseases (diabetic retinopathy, AMD, glaucoma), designed for point-of-care use and offline operation with later synchronization to clinical systems.
Services
Integration of captured imaging and screening outputs with electronic health records using DICOM-compliant data management.
Standardized, centralized training programs and deployment support to ensure consistent use across multiple locations.
Advisory and implementation services to integrate rapid, non-dilated retinal screening into clinical workflows (routine visits, walk-ins, home visits).
Integration of captured imaging and screening outputs with electronic health records using DICOM-compliant data management.
Standardized, centralized training programs and deployment support to ensure consistent use across multiple locations.
Advisory and implementation services to integrate rapid, non-dilated retinal screening into clinical workflows (routine visits, walk-ins, home visits).
Expertise Areas
- Point-of-care retinal imaging
- AI-driven retinal disease screening
- Embedded/edge AI for medical devices
- Medical imaging capture and onboard image processing
Key Technologies
- Fundus retinal imaging (color and infrared)
- Non-mydriatic retinal imaging
- On-device (edge) AI inference
- Embedded image processing pipelines
News & Updates
AI Optics announced it has received FDA 510(k) clearance for its Sentinel Camera, a handheld retinal imaging system that addresses critical gaps in retinal disease screening.
AI Optics announced it has received FDA 510(k) clearance for its Sentinel Camera, a handheld retinal imaging system that addresses critical gaps in retinal disease screening.